Elucidate a low volume high value product giving the example of insulin. Mention the role of Indian companies for its production.
In short
Insulin is a low volume high value product because it needs advanced recombinant biotechnology and strict quality control, yet commands high value as a life-saving diabetes drug. Indian firms such as Biocon pioneered affordable biosimilar insulin, aided by the ₹15,000 crore PLI Scheme and Andhra Pradesh's Bulk Drug Park.
Model answer
Ghissu Editorial · Verified 4 Oct 2026 · 265 words
PLI Scheme for Pharmaceuticals2
With a ₹15,000 crore outlay, the PLI Scheme promotes domestic manufacturing of insulin and critical biopharmaceuticals, enhancing global competitiveness.
Bulk Drug Parks in Andhra Pradesh
Andhra Pradesh benefits from Bulk Drug Parks receiving up to ₹1,000 crore, providing infrastructure crucial for high-value insulin production.
Regulatory Reforms
The new Drugs, Medical Devices and Cosmetics Bill aims to streamline biologics regulation, improving quality and global acceptance of Indian insulin.
Public-Private Partnerships
Indian firms collaborate with research institutions and global pharma, leveraging biotechnology expertise as seen in vaccine production.
Import Dependence on APIs
Indian insulin makers rely heavily on imported APIs, especially from China, affecting costs and supply resilience.
R&D Investment Gaps
Indian pharma’s focus on generics limits innovation in insulin and biologics development.
Access and Affordability
High complexity limits insulin affordability; government schemes like Pradhan Mantri Bhartiya Janaushadhi Pariyojana improve access.
Manufacturing Scale
Indian companies have expanded cGMP-compliant facilities, supporting global supply.
Collaborations and Access
Partnerships with multinationals and government schemes enhance insulin availability in Andhra Pradesh and nationwide.
Regulatory Harmonization and PPPs
Expedite updated regulations and foster collaborations to scale insulin production and distribution.
This model answer is indicative and the model can make mistakes; please verify key facts independently.
Practise this question
1Get the answer sheet
Sized for this question.
2Write your answer
Timed, by hand.
3Get it marked
Your score and what to fix.
This chapter in the exam
Biotechnology & Nanotechnology: scope, ethics, genetic engineering, biodiversity, fermentation, immuno-diagnosis50 questions
Asked in 8 of 8 sittings since 2008
Most tested: Biodiversity and biotechnology governance/ethics, especially conservation, GMOs, and applied public-health biotech.
- 2025Trace the evolution of India's National Biotechnology Development Strategy (NBDS) and discuss its key objectives. Critically evaluate its impact on the growth of the biotechnology sector in India.
- 2025Analyze the potential of plant-derived biopharmaceuticals in promoting sustainable healthcare. Explain how the application of green pharmacy principles can help minimize environmental harm at each stage of the pharmaceutical lifecycle.
All 50 questions, sorted by sub-topic, with model answers and practice.
Question from the official APPSC Group-I Mains 2011 paper. Answer written by Ghissu's engine and checked against our editorial standards. Found an error? Tell us and we correct it within 48 hours.